| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |